Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026



Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Alamir1111 on Mar 27, 2024 5:16pm

Warrants

https://stockhouse.com/news/press-releases/2020/05/11/theralase-announces-warrant-extensionhttps://stockhouse.com/news/press-releases/2020/09/30/theralase-announces-warrant-extensionhttps://stockhouse.com/news/press-releases/2021/01/08/theralase-announces-warrant-extensionhttps://stockhouse.com/news/press-releases/2023/01/05/theralase-xae-announces-warrant-extensionhttps://stockhouse.com/news/press-releases/2022/09/29/theralase-xae-announces-warrant-extension
Comment by patience69 on Mar 27, 2024 5:22pm
I'm pretty sure that those warrants can't be extended. The maximum length for warrants I believe is 5 years & they were 5 years to start.  It's puzzling really if the company hopes to get them exercised for the cash or not but what if they have a bigger deal around the corner with less dilution?  Interesting situation 
Comment by O12009 on Mar 27, 2024 5:30pm
The warrants can not be extended. Five years is the max. The plan is to get BTD before hand in hopes the share price rises and the warrants are exercised 
Comment by menoalittle on Mar 27, 2024 5:50pm
Well, I checked, and you're right.  The OSC has warrants capped at 5 years, so no extension is possible.  That sure doesn't leave much hope for them being exercised, imo...
Comment by Alamir1111 on Mar 27, 2024 6:04pm
Which warrants you talking about 
Comment by Alamir1111 on Mar 27, 2024 6:09pm
I have the tradable  tlt.w expires Sept 2024 that was issued 2 years ago
Comment by managementfirst on Mar 27, 2024 9:51pm
But TLT did a few times to extension  warrant  time before
Comment by Alamir1111 on Mar 27, 2024 5:30pm
Sept 2024 warrantshttps://stockhouse.com/news/press-releases/2022/09/22/theralase-xae-closes-2-5m-private-placement-equity-financing
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     


Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250